Cargando…
MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
INTRODUCTION: Metabolic associated fatty liver disease (MAFLD) is a novel concept for fatty liver disease. Different from non-alcoholic fatty liver disease (NAFLD), the diagnosis of MAFLD requires the presence of metabolic risks. This study aimed to characterize patients with liver steatosis but wit...
Autores principales: | Huang, Jiaofeng, Xue, Wenjuan, Wang, Mingfang, Wu, Yinlian, Singh, Medha, Zhu, Yueyong, Kumar, Rahul, Lin, Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326380/ https://www.ncbi.nlm.nih.gov/pubmed/34349535 http://dx.doi.org/10.2147/DMSO.S316096 |
Ejemplares similares
-
MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
por: Huang, Jiaofeng, et al.
Publicado: (2021) -
Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study
por: Weng, Zhiyuan, et al.
Publicado: (2021) -
Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
por: Huang, Jiaofeng, et al.
Publicado: (2022) -
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022) -
Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III
por: Huang, Jiaofeng, et al.
Publicado: (2022)